Position in IMCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,360,100
+$757,266 QoQ
Shares Held
137,326
+14.9% QoQ
Ownership
0.267%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 136 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Derivatives in IMCR
reported options exposure · as of Mar 31, 2024CallValue
$3,035,500
CallShares
46,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. IMCR ranks #198 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in IMCR
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,360,100 | 137,326 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,602,834 | 119,497 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,124,256 | 32,390 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $2,142,634 | 58,977 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,410,719 | 44,956 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $927,395 | 31,257 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,063,150 | 36,039 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $7,045,995 | 226,341 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,056,335 | 90,184 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,035,500 | 46,700 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $6,292,455 | 96,807 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,325,271 | 48,672 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $3,908,329 | 75,305 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $373,680 | 7,200 | Call | Defined | 2024-05-15 | |
| 2023-06-30 | $5,278,038 | 88,026 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $2,026,051 | 40,980 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $2,473,585 | 43,343 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||